Meanwhile, the abnormal expression of CDK4/6 may be an important sign in the field of CRC and bladder cancer, indicating that hsa‐circ‐000984 may have broad application prospects in the emerging field of molecular markers, which may be a breakthrough in targeted diagnosis of CRC.38, 47. The gene discussed is CDK4; the disease is colorectal carcinoma.